Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-18 4:15 pm Sale | 2023-04-12 | 13G | Amryt Pharma plc AMYT | Athyrium Opportunities III Acquisition 2 LP | 0 0.000% | -44,286,346 (Position Closed) | Filing History |
| 2023-02-14 4:19 pm Sale | 2022-12-31 | 13G | CareMax, Inc. CMAX | Athyrium Opportunities III Acquisition 2 LP | 139,369 3.800% | -10,205 (-6.82%) | Filing History |
| 2022-02-11 4:34 pm Purchase | 2021-12-31 | 13G | CareMax, Inc. CMAX | Athyrium Opportunities III Acquisition 2 LP | 149,574 5.200% | 149,574 (New Position) | Filing History |
| 2021-02-12 08:01 am Purchase | 2020-07-08 | 13G | Amryt Pharma plc AMYT | Athyrium Opportunities III Acquisition 2 LP | 44,286,346 24.800% | 44,286,346 (New Position) | Filing History |